bupropion has been researched along with Chronic Primary Open Angle Glaucoma in 1 studies
Bupropion: A propiophenone-derived antidepressant and antismoking agent that inhibits the uptake of DOPAMINE.
bupropion : An aromatic ketone that is propiophenone carrying a tert-butylamino group at position 2 and a chloro substituent at position 3 on the phenyl ring.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Stein, JD | 1 |
| Talwar, N | 1 |
| Kang, JH | 1 |
| Okereke, OI | 1 |
| Wiggs, JL | 1 |
| Pasquale, LR | 1 |
1 other study available for bupropion and Chronic Primary Open Angle Glaucoma
| Article | Year |
|---|---|
Bupropion use and risk of open-angle glaucoma among enrollees in a large U.S. managed care network.
Topics: Bupropion; Delivery of Health Care; Dose-Response Relationship, Drug; Female; Glaucoma, Open-Angle; | 2015 |